Louis E Nelsen Iii, MD - Medicare Obstetrics/gynecology in Harrisonburg, VA

Louis E Nelsen Iii, MD is a medicare enrolled "Obstetrics & Gynecology" physician in Harrisonburg, Virginia. He went to Eastern Virginia Medical School and graduated in 1986 and has 38 years of diverse experience with area of expertise as Obstetrics/gynecology. He is a member of the group practice Augusta Medical Group and his current practice location is 240 Lucy Dr, Harrisonburg, Virginia. You can reach out to his office (for appointments etc.) via phone at (540) 438-1314.

Louis E Nelsen Iii is licensed to practice in Virginia (license number 0101041968) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1487753372.

Contact Information

Louis E Nelsen Iii, MD
240 Lucy Dr,
Harrisonburg, VA 22801-8036
(540) 438-1314
(540) 438-0797



Physician's Profile

Full NameLouis E Nelsen Iii
GenderMale
SpecialityObstetrics/gynecology
Experience38 Years
Location240 Lucy Dr, Harrisonburg, Virginia
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Louis E Nelsen Iii attended and graduated from Eastern Virginia Medical School in 1986
  NPI Data:
  • NPI Number: 1487753372
  • Provider Enumeration Date: 09/21/2006
  • Last Update Date: 08/17/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 5092985184
  • Enrollment ID: I20111214000029

Medical Identifiers

Medical identifiers for Louis E Nelsen Iii such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1487753372NPI-NPPES
006204937MedicaidVA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207V00000XObstetrics & Gynecology 0101041968 (Virginia)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Augusta HealthFishersville, VAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Augusta Medical Group3678632544316

News Archive

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.

GenSpera presents final data from G-202 Phase I clinical trial at EORTC-NCI-AACR Symposium

GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, presented final data from the G-202 Phase I clinical trial yesterday at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA.

Prostate Cancer Foundation 'beefs up' cancer research

The Prostate Cancer Foundation (PCF) has committed more than $19 million in new research funding for scientific investigations focused on discovering new treatments for recurrent prostate cancer. A total of eight programs representing 18 leading research institutions and 36 researchers were selected as part of the foundation's 2008 Challenge Awards. The funded programs will receive the first of three annual payments, ranging between $500,000 and $1.0 million per program, this week.

Attacking heart failure in the young

Pediatric cardiology experts from around the world will gather at the Indiana University School of Medicine for the inaugural Riley Heart Center Symposium on Cardiac Development Sept. 8-9 at Riley Hospital for Children.

Study: Higher dose of anti-seizure drug during pregnancy may increase baby's risk of cleft lip, palate

Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Louis E Nelsen Iii allows following entities to bill medicare on his behalf.
Entity NameShenandoah Womens Healthcare
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1235112970
PECOS PAC ID: 2163475989
Enrollment ID: O20050222000125

News Archive

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.

GenSpera presents final data from G-202 Phase I clinical trial at EORTC-NCI-AACR Symposium

GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, presented final data from the G-202 Phase I clinical trial yesterday at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA.

Prostate Cancer Foundation 'beefs up' cancer research

The Prostate Cancer Foundation (PCF) has committed more than $19 million in new research funding for scientific investigations focused on discovering new treatments for recurrent prostate cancer. A total of eight programs representing 18 leading research institutions and 36 researchers were selected as part of the foundation's 2008 Challenge Awards. The funded programs will receive the first of three annual payments, ranging between $500,000 and $1.0 million per program, this week.

Attacking heart failure in the young

Pediatric cardiology experts from around the world will gather at the Indiana University School of Medicine for the inaugural Riley Heart Center Symposium on Cardiac Development Sept. 8-9 at Riley Hospital for Children.

Study: Higher dose of anti-seizure drug during pregnancy may increase baby's risk of cleft lip, palate

Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

Read more Medical News

› Verified 2 days ago

Entity NameAugusta Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1245489590
PECOS PAC ID: 3678632544
Enrollment ID: O20081106000590

News Archive

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.

GenSpera presents final data from G-202 Phase I clinical trial at EORTC-NCI-AACR Symposium

GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, presented final data from the G-202 Phase I clinical trial yesterday at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA.

Prostate Cancer Foundation 'beefs up' cancer research

The Prostate Cancer Foundation (PCF) has committed more than $19 million in new research funding for scientific investigations focused on discovering new treatments for recurrent prostate cancer. A total of eight programs representing 18 leading research institutions and 36 researchers were selected as part of the foundation's 2008 Challenge Awards. The funded programs will receive the first of three annual payments, ranging between $500,000 and $1.0 million per program, this week.

Attacking heart failure in the young

Pediatric cardiology experts from around the world will gather at the Indiana University School of Medicine for the inaugural Riley Heart Center Symposium on Cardiac Development Sept. 8-9 at Riley Hospital for Children.

Study: Higher dose of anti-seizure drug during pregnancy may increase baby's risk of cleft lip, palate

Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

Read more Medical News

› Verified 2 days ago

Entity NameObhg Virginia Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1972807394
PECOS PAC ID: 9436323342
Enrollment ID: O20111110000430

News Archive

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.

GenSpera presents final data from G-202 Phase I clinical trial at EORTC-NCI-AACR Symposium

GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, presented final data from the G-202 Phase I clinical trial yesterday at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA.

Prostate Cancer Foundation 'beefs up' cancer research

The Prostate Cancer Foundation (PCF) has committed more than $19 million in new research funding for scientific investigations focused on discovering new treatments for recurrent prostate cancer. A total of eight programs representing 18 leading research institutions and 36 researchers were selected as part of the foundation's 2008 Challenge Awards. The funded programs will receive the first of three annual payments, ranging between $500,000 and $1.0 million per program, this week.

Attacking heart failure in the young

Pediatric cardiology experts from around the world will gather at the Indiana University School of Medicine for the inaugural Riley Heart Center Symposium on Cardiac Development Sept. 8-9 at Riley Hospital for Children.

Study: Higher dose of anti-seizure drug during pregnancy may increase baby's risk of cleft lip, palate

Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Louis E Nelsen Iii is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Louis E Nelsen Iii, MD
Po Box 388,
Fishersville, VA 22939-0388

Ph: (540) 438-1314
Louis E Nelsen Iii, MD
240 Lucy Dr,
Harrisonburg, VA 22801-8036

Ph: (540) 438-1314

News Archive

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.

GenSpera presents final data from G-202 Phase I clinical trial at EORTC-NCI-AACR Symposium

GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, presented final data from the G-202 Phase I clinical trial yesterday at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA.

Prostate Cancer Foundation 'beefs up' cancer research

The Prostate Cancer Foundation (PCF) has committed more than $19 million in new research funding for scientific investigations focused on discovering new treatments for recurrent prostate cancer. A total of eight programs representing 18 leading research institutions and 36 researchers were selected as part of the foundation's 2008 Challenge Awards. The funded programs will receive the first of three annual payments, ranging between $500,000 and $1.0 million per program, this week.

Attacking heart failure in the young

Pediatric cardiology experts from around the world will gather at the Indiana University School of Medicine for the inaugural Riley Heart Center Symposium on Cardiac Development Sept. 8-9 at Riley Hospital for Children.

Study: Higher dose of anti-seizure drug during pregnancy may increase baby's risk of cleft lip, palate

Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

Read more News

› Verified 2 days ago


Obstetrics & Gynecology Doctors in Harrisonburg, VA

Ladene J King, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 2291 Evelyn Byrd Ave, Harrisonburg, VA 22801
Phone: 540-434-3831    
Dr. M Catherine Slusher, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 2291 Evelyn Byrd Ave, Harrisonburg, VA 22801
Phone: 540-434-3831    Fax: 540-432-0518
Dr. C. Larry Whitten, M.D.
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 2291 Evelyn Byrd Ave, Harrisonburg, VA 22801
Phone: 540-434-3831    Fax: 540-432-0518
Sarah C. Mercer, P.A.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 2291 Evelyn Byrd Ave, Harrisonburg, VA 22801
Phone: 540-434-3831    Fax: 540-432-0518
Ms. Jennifer M Visger, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 240 Lucy Dr, Harrisonburg, VA 22801
Phone: 540-438-1314    Fax: 540-438-0797
Nicole M Koiner, CNM
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 240 Lucy Dr, Harrisonburg, VA 22801
Phone: 540-438-1314    Fax: 540-438-0797
Kimberly Ann Greer, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 240 Lucy Dr, Harrisonburg, VA 22801
Phone: 540-438-1314    Fax: 540-438-0797

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.